Kelly G. McCaul, MD
Director Transplant and Cell Therapy Program
Avid reader, loves the outdoors, newest passion is wake surfing.
I am a family man with twin girls and a son in various colleges in the southeast. I feel blessed to be able to help start the Transplant and Cell Therapy Program for the Univ of TN.
Clinical Focus:
Leukemias, lymphomas, myelodysplastic syndrome, multiple myeloma, stem cell, marrow transplant, the newer field of cell therapy including CAR-T therapies
Specialties:
Transplant and Cellular Therapy
Education & Credentials
Medical School
Queens University, Kingston, Ontario, 1992
Internships
Internal Medicine, Dalhousie University, Halifax, Nova Scotia, Canada
Residencies
Internal Medicine, Dalhousie University, Halifax, Nova Scotia, 1996
Fellowships
Leukemia and Bone Marrow Transplant Program of British Columbia, Vancouver, British Columbia, 2000 Hematology, Dalhousie University, Halifax, Nova Scotia, 1997 Leukemia and Transplant Fellowship, Vancouver General Hospital/British Columbia Cancer Agency, Vancouver, British Columbia
Board Certifications
Fellow, Royal College of Physicians and Surgeons of Canada American Board of Internal Medicine
Organizations & Societies
American Society of Hematology
I have spent my life caring for people, and helping them get through difficult situations. I feel like the culmination of those decades has brought me here to Tennessee to help take care of the patients I see every day from this region.
— Kelly G. McCaul
My Featured
Content
WBIR: UT Medical Center is first in Tennessee to offer newly FDA-approved melanoma treatment
Author: Lauren Davis, WBIR
Dr. Kelly McCaul
Click to learn more about Dr. Kelly McCaul.
